coumarin has been researched along with paclitaxel in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, R; Liu, Y; She, M; Wu, Z | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Xu, Z; Zhang, L | 1 |
| Dubrovskyi, O; Dye, K; Gutgesell, LM; Huang, F; Li, Y; Ratia, K; Shen, Z; Thatcher, GRJ; Tonetti, DA; Xiong, R; Zhao, H; Zhao, J | 1 |
| Shimada, T; Yamazaki, H | 1 |
| Ekman, S; Fransson-Steen, R; Hagbjörk, AL; Löfgren, S; Terelius, Y | 1 |
| Dong, Y; Feng, SS | 1 |
| Callaghan, R; Kerr, ID; McMahon, R; Rothnie, A; Storm, J; Taylor, A | 1 |
| Hayashi, Y; Hirota, S; Kimura, T; Kiso, Y; Noguchi, M; Prakash, H; Skwarczynski, M | 1 |
| Adamo, L; Conticello, C; De Maria, R; Giannone, I; Gulisano, M; Musumeci, T; Pignatello, R; Puglisi, G; Vicari, L | 1 |
| Delaporte, E; Rodrigues, AD | 1 |
| Dilnawaz, F; Jagannathan, NR; Mewar, S; Sahoo, SK; Sharma, U; Singh, A | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L | 1 |
| Jiang, TY; Lv, HX; Zhang, YL; Zhang, ZH; Zhou, JP | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Jiang, X; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, X; Kang, T; Liu, Z; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
| He, G; Huang, W; Li, B; Peng, C; Song, X; Wu, F; Zeng, S; Zheng, Y | 1 |
| Baker, JR; Cannon, J; Choi, SK; Gam, K; Isham, D; Mukherjee, J; Payne, M; Tang, S; Wong, PT; Yanik, SA | 1 |
| Cheng, F; Gong, YC; Li, YP; Li, ZL; Pan, X; Tao, L; Xiong, XY | 1 |
| Bian, Y; Leng, X; Li, Y; Tu, Z; Wang, W; Wang, Z; Wei, Z; Zheng, L | 1 |
1 review(s) available for coumarin and paclitaxel
| Article | Year |
|---|---|
Coumarin-containing hybrids and their anticancer activities.
Topics: Animals; Antineoplastic Agents; Coumarins; Drug Design; Drug Discovery; Humans; Neoplasms; Structure-Activity Relationship | 2019 |
19 other study(ies) available for coumarin and paclitaxel
| Article | Year |
|---|---|
The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Topics: Cytochrome P-450 Enzyme Inhibitors; Enzyme Activation; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Molecular Structure; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.
Topics: Animals; Breast Neoplasms; Drug Resistance, Neoplasm; Fulvestrant; Humans; MCF-7 Cells; Mice; Models, Molecular; Piperazines; Protein Domains; Pyridines; Pyridones; Receptors, Estrogen; Tissue Distribution; Transcription Factors; Xenograft Model Antitumor Assays | 2020 |
Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
Topics: Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Cholecalciferol; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Ethanolamines; Humans; Isoenzymes; Lauric Acids; Microsomes, Liver; Mixed Function Oxygenases; Nifedipine; Omeprazole; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Paclitaxel; Prostaglandins; Recombinant Proteins; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline; Tretinoin; Warfarin; Xenobiotics | 1999 |
Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison.
Topics: Amiodarone; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Chlorzoxazone; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dextromethorphan; Diclofenac; DNA, Complementary; Ethanolamines; Female; Humans; Kinetics; Lauric Acids; Male; Mephenytoin; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Microsomes, Liver; Mixed Function Oxygenases; NADP; Nitrophenols; Oxidoreductases, N-Demethylating; Oxygen; Paclitaxel; Phenacetin; Rats; Sex Factors; Species Specificity; Substrate Specificity; Testosterone | 2004 |
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Topics: Administration, Oral; Antineoplastic Agents; Bentonite; Biocompatible Materials; Caco-2 Cells; Coumarins; Drug Carriers; Drug Delivery Systems; Fluorescent Dyes; Gastrointestinal Tract; HT29 Cells; Humans; In Vitro Techniques; Lactic Acid; Microscopy, Atomic Force; Microscopy, Confocal; Nanotechnology; Paclitaxel; Particle Size; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Solvents; Temperature; Time Factors; X-Ray Diffraction | 2005 |
The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Baculoviridae; Binding Sites; Catalysis; Cell Line; Cell Membrane; Coumarins; Cysteine; Hydrolysis; Insecta; Kinetics; Linear Models; Mutagenesis, Site-Directed; Nicardipine; Paclitaxel; Protein Binding; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Protein Transport; Quinolines; Recombinant Proteins; Sulfhydryl Compounds; Time Factors; Vinblastine | 2005 |
Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs.
Topics: Chromatography, High Pressure Liquid; Coumarins; Drug Design; Lasers; Molecular Conformation; Paclitaxel; Photochemistry; Photolysis; Photosensitizing Agents; Prodrugs; Solubility; Stereoisomerism; Ultraviolet Rays; Water | 2008 |
Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Colloids; Coumarins; Drug Carriers; Hematologic Neoplasms; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Neoplasms; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2008 |
Cytochrome p450 assays.
Topics: Animals; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Enzyme Inhibitors; Humans; Mephenytoin; Paclitaxel; Phenacetin; Testosterone | 2002 |
The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Cell Death; Cell Line, Tumor; Coumarins; Endocytosis; Half-Life; HEK293 Cells; Humans; Intracellular Space; Liver; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Membrane Glycoproteins; Microscopy, Confocal; Models, Animal; Paclitaxel; Particle Size; Rats; Rats, Wistar; Solutions; Surface-Active Agents; Tissue Distribution | 2012 |
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coumarins; Diagnostic Imaging; Drug Delivery Systems; Endocytosis; Ethylene Oxide; Glioblastoma; Kaplan-Meier Estimate; Lactones; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; Paclitaxel; Protamines; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Tissue Distribution | 2013 |
Cell uptake of paclitaxel solid lipid nanoparticles modified by cell-penetrating peptides in A549 cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Coumarins; Dialysis; Dose-Response Relationship, Drug; Humans; Lipids; Microscopy, Atomic Force; Microscopy, Fluorescence; Nanoparticles; Paclitaxel; Particle Size; Peptides | 2013 |
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Coumarins; Diagnostic Imaging; Endocytosis; Glioma; Male; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Paclitaxel; Rats; Spheroids, Cellular; Survival Analysis; Tissue Distribution | 2013 |
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cell-Penetrating Peptides; Coumarins; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats; Spectroscopy, Near-Infrared; Spheroids, Cellular; Tissue Distribution | 2013 |
Synthesis, characterization, and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Cholesterol; Coumarins; Drug Delivery Systems; Drug Evaluation, Preclinical; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Mice; Oligopeptides; Paclitaxel; Polyethylene Glycols | 2014 |
A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging.
Topics: Benzaldehydes; Cell Line, Tumor; Cell Survival; Coumarins; Doxorubicin; Drug Carriers; Drug Liberation; Fluorescent Dyes; Humans; Kinetics; Paclitaxel; Photolysis; Ultraviolet Rays | 2017 |
Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel.
Topics: Animals; Biological Transport; Cell Line, Tumor; Coumarins; Drug Carriers; Folic Acid; Humans; Intracellular Space; Male; Micelles; Paclitaxel; Poloxamer; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Succinates; Tissue Distribution | 2017 |
Development of biodegradable polyesters based on a hydroxylated coumarin initiator towards fluorescent visible paclitaxel-loaded microspheres.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Line, Tumor; Coumarins; Drug Carriers; Materials Testing; Mice; Microspheres; Paclitaxel; Polyesters | 2019 |